These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 22238444)
41. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity. Humphries RM; Uslan DZ; Rubin Z J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736 [TBL] [Abstract][Full Text] [Related]
42. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing? Leslie JL; Cohen SH; Solnick JV; Polage CR Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877 [TBL] [Abstract][Full Text] [Related]
43. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests. Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711 [TBL] [Abstract][Full Text] [Related]
44. Comparison of testing approaches for Clostridium difficile infection at a large community hospital. Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523 [TBL] [Abstract][Full Text] [Related]
47. Unnecessary repeat Clostridium difficile PCR testing in hospitalized adults with C. difficile-negative diarrhea. Nistico JA; Hage JE; Schoch PE; Cunha BA Eur J Clin Microbiol Infect Dis; 2013 Jan; 32(1):97-9. PubMed ID: 23010903 [TBL] [Abstract][Full Text] [Related]
48. Current status of Clostridium difficile infection epidemiology. Lessa FC; Gould CV; McDonald LC Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S65-70. PubMed ID: 22752867 [TBL] [Abstract][Full Text] [Related]
49. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. Eastwood K; Else P; Charlett A; Wilcox M J Clin Microbiol; 2009 Oct; 47(10):3211-7. PubMed ID: 19710274 [TBL] [Abstract][Full Text] [Related]
50. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan. Chang FC; Liu CP; Sun FJ; Lin CC J Microbiol Immunol Infect; 2021 Apr; 54(2):284-289. PubMed ID: 31624018 [TBL] [Abstract][Full Text] [Related]
58. Severe clinical outcome is uncommon in Clostridium difficile infection in children: a retrospective cohort study. Schwartz KL; Darwish I; Richardson SE; Mulvey MR; Thampi N BMC Pediatr; 2014 Jan; 14():28. PubMed ID: 24485120 [TBL] [Abstract][Full Text] [Related]
59. A multicenter evaluation of a sample to answer real-time PCR assay for toxigenic C. difficile in symptomatic subjects. Pancholi P; Young S; Widen R; Silbert S; Schmitt B; Dunn R; Drain A; Weissfeld SA Diagn Microbiol Infect Dis; 2020 Jan; 96(1):114920. PubMed ID: 31699545 [TBL] [Abstract][Full Text] [Related]
60. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior. Olmedo M; Alcalá L; Valerio M; Marín M; Onori R; Reigadas E; Muñoz P; Bouza E Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115050. PubMed ID: 32482380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]